TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21625083

Group type: EXPERIMENTAL
Intervention: Early initiation of hemodialysis at an estimated glomerular filtration rate (eGFR) of 10‐14 ml/min
Number of subjects: 362

Group type: COMPARATOR
Intervention: Late initiation of hemodialysis at an estimated glomerular filtration rate (eGFR) of 5‐7 ml/min
Number of subjects: 362

Group type: COMPARATOR
Intervention: Late initiation of hemodialysis
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Early initiation of hemodialysis
Number of subjects: 362
Study: 19365548

Group type: EXPERIMENTAL
Intervention: Naltrexone (50mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16578980

Group type: EXPERIMENTAL
Intervention: DEET
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: permethrin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: stress (combat videotape plus mental arithmetic)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: blinding
Number of subjects: 10
Study: 12770957

Group type: EXPERIMENTAL
Intervention: Manual Small Incision Cataract Surgery (MSICS)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Extracapsular Cataract Surgery (ECCE)
Number of subjects: 741
Study: 10685792

Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 to 4 mg/kg/day) plus MTX
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 40
Study: 9058181

Group type: EXPERIMENTAL
Intervention: music imaging
Number of subjects: 78

Group type: COMPARATOR
Intervention: silent imaging
Number of subjects: 78

Group type: COMPARATOR
Intervention: music listening
Number of subjects: 78

Group type: COMPARATOR
Intervention: control conditions
Number of subjects: 78
Study: 8088933

Group type: EXPERIMENTAL
Intervention: Heparan sulfate pharmacodynamics identification programme using a personal computer
Number of subjects: 0
Study: 3537785

Group type: COMPARATOR
Intervention: Placebo (Group A)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Prophylactic ketoconazole, 400 mg daily for five days beginning with the onset of menses for six menstrual cycles (Group B)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low-dose ketoconazole, 100 mg daily for six months (Group C)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Prophylactic ketoconazole (Group B)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low-dose ketoconazole (Group C)
Number of subjects: 74
Study: 30620641

Group type: EXPERIMENTAL
Intervention: Enhanced Hybrid Closed Loop (e-HCL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard Hybrid Closed Loop (s-HCL)
Number of subjects: 11
Study: 29530423

Group type: EXPERIMENTAL
Intervention: Community-based educational intervention involving screening and structured discussion of a 52-min movie, and the SARAR approach via the PHAST model.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Community-based educational intervention
Number of subjects: 58
Study: 27380603

Group type: EXPERIMENTAL
Intervention: Ditto Preparation and Distraction
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard Distraction
Number of subjects: 98
Study: 23572413

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg orally three times a day for 48 hours
Number of subjects: 199

Group type: COMPARATOR
Intervention: Saline (hydration)
Number of subjects: 199
Study: 22159966

Group type: EXPERIMENTAL
Intervention: Topical Mitomycin C
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline-soaked pledget (control)
Number of subjects: 50
Study: 20123205

Group type: EXPERIMENTAL
Intervention: Cryoplasty
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional angioplasty
Number of subjects: 86
Study: 17347975

Group type: EXPERIMENTAL
Intervention: i.v. L-propionyl carnitine treatment for two months
Number of subjects: 14
Study: 12663237

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg/day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Propranolol 40-120 mg/day
Number of subjects: 34
Study: 11010580

Group type: EXPERIMENTAL
Intervention: DOSA pathway with domiciliary post acute care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional clinical pathways
Number of subjects: 0
Study: 9295114

Group type: EXPERIMENTAL
Intervention: Imagining right hand grasping the screwdriver
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagining left hand grasping the screwdriver
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left-handers imagining left hand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left-handers imagining right hand
Number of subjects: 0
Study: 8290486

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltaren) alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ranitidine HCl (Zantac) alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium and ranitidine HCl in combination (V/Z)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Diclofenac sodium alone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ranitidine HCl alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination treatment (V/Z)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Gastric residence time for Treatments V, Z, and V/Z
Number of subjects: 18
Study: 3728581

Group type: EXPERIMENTAL
Intervention: 1 gm of oral tryptophan (group T)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 100 gm of oral glucose (group G)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1 gm of oral tryptophan and 100 gm of oral glucose (group T + G)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fasting (group C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 40
Study: 29391363

Group type: EXPERIMENTAL
Intervention: Interorganisational educational intervention 'The Meeting Point'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (hospital and nursing home)
Number of subjects: 0
Study: 26957102

Group type: EXPERIMENTAL
Intervention: Continuous Epidural Analgesia (CEA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intravenous Patient Controlled Analgesia (IV-PCA)
Number of subjects: 80
Study: 24399553

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg, 2 per day) with cognitive behavioral therapy
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo with cognitive behavioral therapy
Number of subjects: 247
Study: 23250157

Group type: EXPERIMENTAL
Intervention: Colgate Total (fluoride abrasive dentifrice)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Natural White (whitening dentifrice)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Opalescence (10% carbamide peroxide) brushed with Colgate Total
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Opalescence (10% carbamide peroxide) brushed with Natural White
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water (Control group)
Number of subjects: 40
Study: 20020208

Group type: EXPERIMENTAL
Intervention: Family functioning
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Disclosure
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: ARV adherence
Number of subjects: 409
Study: 18436195

Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 1 g orally twice daily (b.i.d.)
Number of subjects: 140
Study: 16148700

Group type: EXPERIMENTAL
Intervention: Ligasure tonsillectomy (LT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cold knife tonsillectomy (CKT)
Number of subjects: 200
Study: 12687827

Group type: EXPERIMENTAL
Intervention: DDD+ pacing
Number of subjects: 75

Group type: COMPARATOR
Intervention: DDD pacing
Number of subjects: 75
Study: 11297005

Group type: EXPERIMENTAL
Intervention: Fructose (FG)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Glucose (GG)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 17
Study: 9010695

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1642682

Group type: EXPERIMENTAL
Intervention: Soluble ibuprofen 200 mg sachets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soluble ibuprofen 400 mg sachets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen 200 mg tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg tablets
Number of subjects: 0
Study: 6503136

Group type: EXPERIMENTAL
Intervention: Bumetanide (1.0 and 2.0 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Furosemide (40 and 80 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of Bumetanide and Furosemide
Number of subjects: 20
Study: 30977033

Group type: EXPERIMENTAL
Intervention: TDF 300 mg
Number of subjects: 498

Group type: COMPARATOR
Intervention: ADV 10 mg
Number of subjects: 498
Study: 30100318

Group type: EXPERIMENTAL
Intervention: Thai massage (TM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Swedish massage (SM)
Number of subjects: 20
Study: 27320832

Group type: EXPERIMENTAL
Intervention: Ballistic strength training (3 sessions of 60 minutes per week for 12 weeks) targeting ankle plantarflexors, hip flexors, and hip extensors.
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual care (3 sessions of 60 minutes per week for 12 weeks) including balance, strength, stretch, cardiovascular fitness, gait.
Number of subjects: 166
Study: 24117487

Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 122
Study: 22663899

Group type: EXPERIMENTAL
Intervention: Substance‐Free Activity Session (SFAS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 82
Study: 19580713

Group type: EXPERIMENTAL
Intervention: Fibrin glue spray applied to the axillary fossa in 45 patients
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional treatment in 45 patients
Number of subjects: 90
Study: 17785082

Group type: EXPERIMENTAL
Intervention: 10-hydroxy-camptothecin (10-HCPT) 10 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10-hydroxy-camptothecin (10-HCPT) 12 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10-hydroxy-camptothecin (10-HCPT) 14 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10-hydroxy-camptothecin (10-HCPT) 8 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10-hydroxy-camptothecin (10-HCPT) 4 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10-hydroxy-camptothecin (10-HCPT) 6 mg/m2 with 5-fluoro-uracil (5-FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2
Number of subjects: 18
Study: 12792005

Group type: EXPERIMENTAL
Intervention: Trained dispensing staff (Family welfare educators and pharmacy technicians)
Number of subjects: 2994

Group type: EXPERIMENTAL
Intervention: Untrained staff
Number of subjects: 2994

Group type: EXPERIMENTAL
Intervention: Analgesics
Number of subjects: 2994

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 2994

Group type: EXPERIMENTAL
Intervention: Patient knowledge assessment
Number of subjects: 2994
Study: 11104737

Group type: EXPERIMENTAL
Intervention: Intravenously infused nitroglycerin (NTG) for 24 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no nitrate therapy)
Number of subjects: 0
Study: 8729711

Group type: EXPERIMENTAL
Intervention: Anxiety-related words (stressor)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Neutral control words
Number of subjects: 25
Study: 1735586

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nifedipine 40 mg/day
Number of subjects: 30
Study: 6683976

Group type: EXPERIMENTAL
Intervention: Rectal absorption from aqueous solution
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rectal absorption from fatty suppository
Number of subjects: 7

Group type: COMPARATOR
Intervention: Oral dosing of codeine phosphate (60 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rectal absorption from alkaline solution containing codeine phosphate
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Various rectal dosage forms
Number of subjects: 7
Study: 30973437

Group type: EXPERIMENTAL
Intervention: Nature sounds
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Foot reflexology massage
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nature sounds plus foot sole reflexology massage
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 28625242

Group type: EXPERIMENTAL
Intervention: miR‐182 in CI group (2.35±0.79)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Th17% in CI group (5.16±1.89)%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IL‐17 in CI group (37.45±6.20 ng/L)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined miR‐182 and IL‐17
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: miR‐182 cut-off value
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IL‐17 cut-off value
Number of subjects: 30
Study: 26521571

Group type: EXPERIMENTAL
Intervention: Combined therapy of acupuncture at head points and seed-pressure at ear points
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simple acupuncture at head points
Number of subjects: 30
Study: 23561971

Group type: EXPERIMENTAL
Intervention: Pancreatin (Creon(®) 40000 MMS™) at a dose of 80,000 Ph. Eur. lipase units with each of three main meals/day and 40,000 with each of up to three snacks/day
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Treatment-emergent adverse events (TEAEs)
Number of subjects: 61
Study: 21613389

Group type: EXPERIMENTAL
Intervention: Computer-delivered treatment (CDT)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 303
Study: 19892281

Group type: EXPERIMENTAL
Intervention: Banded rapid maxillary expander
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (NTG)
Number of subjects: 60
Study: 16426292

Group type: EXPERIMENTAL
Intervention: High-fat petrolatum-based moisturizer
Number of subjects: 644

Group type: COMPARATOR
Intervention: Protective gloves
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Information and discussions on prevention of skin problems
Number of subjects: 644
Study: 16636488

Group type: EXPERIMENTAL
Intervention: valsartan
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: valsartan plus angiotensin converting enzyme (ACE) inhibitor
Number of subjects: 500

Group type: COMPARATOR
Intervention: valsartan plus ACE inhibitor
Number of subjects: 500
Study: 10560360

Group type: EXPERIMENTAL
Intervention: Fluconazole 50 mg, twice daily
Number of subjects: 213

Group type: COMPARATOR
Intervention: Itraconazole 100 mg, twice daily
Number of subjects: 213
Study: 8900706

Group type: EXPERIMENTAL
Intervention: Daily condom catheter change
Number of subjects: 113

Group type: COMPARATOR
Intervention: Every other day condom catheter change
Number of subjects: 113
Study: 2069791

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg or 180 mg twice daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Diltiazem 240 mg once daily
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg twice daily
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg twice daily
Number of subjects: 34
Study: 6840169

Group type: EXPERIMENTAL
Intervention: Sobrerol (mucolytic drug)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement of serum and urine levels of Sobrerol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mass fragmentographic analysis
Number of subjects: 0
Study: 31595433

Group type: EXPERIMENTAL
Intervention: Ophthalmic 0.3% gentamicin topical solution nightly for a 3-month period
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Wound cultures of nail plates
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dermatopathology
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clinical examination findings
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dermoscopic findings
Number of subjects: 26
Study: 30995686

Group type: EXPERIMENTAL
Intervention: Tailored tele-monitoring intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 27808005

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT-E), 40 sessions
Number of subjects: 106

Group type: COMPARATOR
Intervention: Focal Psychodynamic Therapy (FPT), 40 sessions
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT-E)
Number of subjects: 106
Study: 26479969

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB) plus bare-metal stent (BMS) implantation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS) alone
Number of subjects: 120
Study: 24508103

Group type: EXPERIMENTAL
Intervention: vemurafenib (960 mg orally twice daily)
Number of subjects: 675

Group type: COMPARATOR
Intervention: dacarbazine (1000 mg/m² IV every 3 weeks)
Number of subjects: 675
Study: 23204602

Group type: EXPERIMENTAL
Intervention: Active CPAP
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 1098
Study: 20920276

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy with capecitabine (825 mg/m² twice daily during radiotherapy)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy with capecitabine
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Preoperative combined therapy
Number of subjects: 57
Study: 18547150

Group type: EXPERIMENTAL
Intervention: 0.6 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 0.9 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 1.2 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 15814754

Group type: EXPERIMENTAL
Intervention: 15 mL of ropivacaine 0.5%
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 20 mL of ropivacaine 0.5%
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 25 mL of ropivacaine 0.5%
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 30 mL of ropivacaine 0.5%
Number of subjects: 84
Study: 12432177

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CM; 0.3 g kg d 1 + 20 g Polycose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lacto‐ovo‐vegetarian diet (LOV)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Omnivorous diet (Omni)
Number of subjects: 32
Study: 10499778

Group type: EXPERIMENTAL
Intervention: EPO (100 U/kg) for 3 months, 3 times per week
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: EPO (50% decreased dose) + vitamin E (300 mg/day) for 3 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Untreated group (no intervention)
Number of subjects: 46
Study: 8613890

Group type: EXPERIMENTAL
Intervention: Wheat fiber-supplemented diet (40 g dietary fiber)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control diet (15 g dietary fiber)
Number of subjects: 7
Study: 1758713

Group type: EXPERIMENTAL
Intervention: Auricular transcutaneous electrical nerve stimulation (TENS) at autonomic point
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Auricular transcutaneous electrical nerve stimulation (TENS) at wrist point
Number of subjects: 24

Group type: COMPARATOR
Intervention: Auricular transcutaneous electrical nerve stimulation (TENS) at face point (placebo)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated group (situation control)
Number of subjects: 24
Study: 30851191

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2629
Study: 28612077

Group type: EXPERIMENTAL
Intervention: Active rTMS (5 Hz, 3,000 pulses) applied on the tongue area of the motor cortex for 10 days over 2 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 15
Study: 26036554

Group type: EXPERIMENTAL
Intervention: Epidural morphine (2 mg) via patient-controlled epidural analgesia (PCEA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous (IV) morphine (5 mg) with patient-controlled analgesia (PCA)
Number of subjects: 40
Study: 23503736

Group type: EXPERIMENTAL
Intervention: Treadmill training without partial weight support
Number of subjects: 36

Group type: COMPARATOR
Intervention: Overground walking training on a fixed surface
Number of subjects: 36
Study: 21305271

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 36
Study: 19667239

Group type: EXPERIMENTAL
Intervention: Combined criteria (Doppler and morphology-based)
Number of subjects: 2170

Group type: COMPARATOR
Intervention: WHO criteria (exclusively Doppler-based)
Number of subjects: 2170
Study: 18091408

Group type: EXPERIMENTAL
Intervention: Case-management (CM) plus usual primary care
Number of subjects: 419

Group type: COMPARATOR
Intervention: Primary care alone
Number of subjects: 419
Study: 15085385

Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 405

Group type: COMPARATOR
Intervention: MACOP-B (methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: P-glycoprotein expression
Number of subjects: 405
Study: 11346128

Group type: EXPERIMENTAL
Intervention: Day hospital care for 2 months
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (no day hospital care)
Number of subjects: 174
Study: 9715842

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (20 mg/m2 every 3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liposomal daunorubicin (40 mg/m2 every 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liposomal daunorubicin
Number of subjects: 0
Study: 8021759

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 25
Study: 2657200

Group type: EXPERIMENTAL
Intervention: 0.5% levobunolol
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0.5% timolol
Number of subjects: 31